Bottomley et al identified prognostic factors for patients with malignant mesothelioma. These can help to identify patients who may require more aggressive management. The authors are from multiple institutions in Europe, Egypt and Canada participating in the European Organisation for Research and Treatment of Cancer (EORTC).